Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Elevance Health (ELV)
NYSE:ELV
Holding ELV?
Track your performance easily
Earnings Data
Report Date
Jan 23, 2025TBA Not Confirmed
Period Ending
2025 (Q1)Consensus EPS Forecast
10.72Last Year’s EPS
10.64Same Quarter Last Year
Moderate Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Oct 31, 2018
|% Change Since: 2.45%
|Next Earnings Date:Jul 25, 2018
Earnings Call Sentiment|Neutral
The earnings call presented a mixed sentiment with strong growth in Medicare Advantage and commercial businesses, alongside challenges in Medicaid cost trends and membership reductions. The company is confident in navigating these challenges and executing growth strategies.Company Guidance
During the Elevance Health fourth-quarter earnings call for 2024, key guidance metrics were highlighted, with adjusted diluted earnings per share projected to be in the range of $34.15 to $34.85 for 2025. The company anticipates Medicare Advantage membership growth between 7% to 9%, consistent with prior expectations. The Medicaid business faced elevated cost trends, with a focus on improving margins through anticipated rate adjustments in the latter half of 2025. Elevance Health expects operating revenue growth in the high single to low double-digit range, bolstered by acquisitions such as CareBridge. Furthermore, the consolidated medical loss ratio is projected to increase to around 89.1%, and the adjusted operating expense ratio is expected to slightly improve to 10.4%. The company plans to allocate approximately $2.3 billion toward share repurchases, reflecting a strong commitment to shareholder returns.Medicare Advantage Growth
Medicare Advantage membership is expected to grow in the range of 7% to 9%, consistent with prior expectations, with strong member retention and group membership growth.
Strong Commercial Business Performance
Elevance Health welcomed 18 new national accounts and experienced record retention for 2025, contributing to strong revenue growth in the commercial segment.
Carelon Services Growth
Carelon Services experienced impressive growth with internal and external expansion, reaching over 50% growth, driven by acquisitions like CareBridge and strong organic growth.
Adjusted EPS Guidance for 2025
Guidance for adjusted diluted earnings per share is set at $34.15 to $34.85, with a focus on managing cost trends and executing growth opportunities.
---
ELV Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
ELV Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Jan 23, 2025 | $390.73 | $401.36 | +2.72% |
| Oct 17, 2024 | $494.94 | $442.54 | -10.59% |
| Jul 17, 2024 | $549.24 | $517.25 | -5.82% |
| Apr 18, 2024 | $503.85 | $519.90 | +3.19% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Elevance Health (ELV) report earnings?
Elevance Health (ELV) is schdueled to report earning on Jan 23, 2025, TBA Not Confirmed.
What is Elevance Health (ELV) earnings time?
Elevance Health (ELV) earnings time is at Jan 23, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is ELV EPS forecast?
ELV EPS forecast for the fiscal quarter 2025 (Q1) is 10.72.
---
